Skip to content
    • DeutschDeutsch
    • FrançaisFrançais
    • EspañolEspañol
  • COVID-19 Rapid Antibody Test
  • Customer Services
  • Investors
  • Careers
abingdon-health
Contact
  • Who We Are
    • Vision and Mission
    • Board of Directors
    • Leadership Team
    • Medical and Scientific Advisory Board
    • Quality Standards
    • Our Community
    • Careers
  • Services
    • Full Service
    • Lateral Flow Development
    • Lateral Flow Manufacturing
    • Readers and Data Platforms
    • Gold nanoparticles and custom conjugation
    • Nucleic Acid Lateral Flow Customisation
    • Our Customers’ Industries
    • Quotation Request
  • Products
    • AbC-19 Rapid Test
    • PCRD
    • Seralite®
    • Quotation Request
  • Knowledge Centre
    • Blogs
    • Brochures & Guides
    • Videos
    • Glossary of Terms
    • FAQs
    • What is a Lateral Flow Test?
  • News & Events
    • Latest News
    • Events
    • Newsletter
  • Contact Us
  • Customer Services
  • Investors Home
  • Careers
    • DeutschDeutsch
    • FrançaisFrançais
    • EspañolEspañol

Home Investors Home Latest News

Latest News

  • Investors Home
  • Documents and Reports
  • AIM Rule 26
  • Board and Governance
  • Shareholders
  • Regulatory Announcements
  • Latest News

Latest Investor News

  • Performance data on AbC-19™ as a companion test to the Pfizer-BioNTech COVID-19 vaccine

    news | 24 Feb 2021

    Performance data on AbC-19™ as a companion test to the Pfizer-BioNTech COVID-19 vaccine
  • Abingdon Health signs collaboration and co-marketing agreement with Abcam

    news | 09 Feb 2021 | 4 mins

    Abingdon Health signs collaboration and co-marketing agreement with Abcam
  • Trading Update

    news | 26 Jan 2021 | 7 mins

    Trading Update
  • Appointment of Chief Financial Officer

    news | 26 Jan 2021 | 1 min

    Appointment of Chief Financial Officer
  • Admission on AIM market of the London Stock Exchange

    news | 15 Dec 2020 | 1 min

    Admission on AIM market of the London Stock Exchange
  • Abingdon Health appoints Mary Tavener as Non-Executive Director

    news | 30 Oct 2020 | 2 mins

    Abingdon Health appoints Mary Tavener as Non-Executive Director
  • £1M funding for the development of a quantitative lateral flow Smartphone Reader

    news | 17 Sep 2020 | 3 mins

    £1M funding for the development of a quantitative lateral flow Smartphone Reader
  • UK COVID-19 rapid antibody tests approved for professional use

    news | 30 Jul 2020

    UK COVID-19 rapid antibody tests approved for professional use
  • Design freeze for AbC-19™ lateral flow test for IgG antibodies to the SARS-COV-2 virus

    news | 29 Jun 2020 | 3 mins

    Design freeze for AbC-19™ lateral flow test for IgG antibodies to the SARS-COV-2 virus
  • Abingdon Health appoints Professor Mike Holmes as a medical advisor

    news | 24 Jun 2020 | 2 mins

    Abingdon Health appoints Professor Mike Holmes as a medical advisor
  • Abingdon Health appoints Lyn Rees as Non-Executive Director

    news | 22 Jun 2020 | 2 mins

    Abingdon Health appoints Lyn Rees as Non-Executive Director
  • Abingdon Health announces its latest expansion and additional manufacturing capacity

    news | 17 Jun 2020 | 3 mins

    Abingdon Health announces its latest expansion and additional manufacturing capacity
  • Who We Are
    • Vision and Mission
    • Quality Standards
    • Our Community
    • Careers
  • Services
    • Full Service
    • Lateral Flow Development
    • Lateral Flow Manufacturing
    • Readers and Data Platforms
    • Nucleic Acid Lateral Flow Customisation
    • Our Customers’ Industries
    • USA and Canada
  • Products
    • AbC-19 Rapid Test
    • PCRD
    • Seralite®
  • Thought Leadership
    • Knowledge Centre
    • News & Events
Get in touch

[email protected]
+44 (0)1904 406 082

Abingdon Health Head Office
York Biotech Campus
Sand Hutton
York
YO41 1LZ
United Kingdom

  • Twitter
  • LinkedIn
  • YouTube

© Abingdon Health 2021

  • Careers
  • Privacy
  • Terms
  • Cookies
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkCookie policy